Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 17 | - |
| 2 | Schedule 2 | MAHAVIR MEDICOSLikely | 1 | ₹17,150 |
| 3 | Schedule 3 | KANAK ENTERPRISESLikely | 1 | ₹28,500 |
| 4 | Schedule 4 | Not yet disclosed by govt.Likely | 17 | - |
| 5 | Schedule 5 | SUKUN PHARMALikely | 7 | ₹500 |
Tender Value
₹1.3 L
EMD Value
Exempted
Closing Date
10 Jul 2026, 2:00 pmClosed
ECHS CFA 01
9537463
GEM/2026/B/7725754
Two Packet Bid
Atorvastatin 20 mg tab,Gabapentin 300mg tab obilique cap,Pantaprozole 40 mg and domperidone 10 mg,P
Ajmer, Rajasthan
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹1 L
₹1 L
50%
Commandant, Military Hospital Nasirabad, Department of Military Affairs, Indian Army, Ministry of Defence, (Military Hospital Nasirabad)
Exempted
Yes
10 Jul 2026
30 Jun 2026
10 Jul 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Atorvastatin 20 mg tab | as per pdf | 20,000 | No | AJMER | 15 |
| 2 | Gabapentin 300mg tab obilique cap | as per pdf | 5,000 | No | AJMER | 15 |
| 3 | Pantaprozole 40 mg and domperidone 10 mg | as per pdf | 10,000 | No | AJMER | 15 |
| 4 | Pantoprazole 40 mg and levosulpiride 75 mg cap | as per pdf | 5,000 | No | AJMER | 15 |
| 5 | Carvedilol 12.5 mgTab | as per pdf | 1,000 | No | AJMER | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9537463.pdf
GEM_BID • 0.13 MB
pdf_tech_02_2026-06-30-13-02-03_1d0fe96b8b9be1ae1e98d48a6ff6e6a7.pdf
BOQ • 0.29 MB
boq_item_sample_file-1_2026-06-30-13-02-03_2911235364cfd9dbb8afdf93c45a4b98.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .